About Us

Stilla Technologies is a Paris-based biotechnology company whose mission is to improve health by offering researchers and clinicians worldwide solutions for high precision genetic analysis.

Since 2016, Stilla Technologies has empowered researchers with the naica™ system, a solution that enables to detect & quantity DNA with unprecedented precision.

The naica™ system supports a wide range of genetic tests and molecular biology assays — including liquid biopsy tests for cancer diagnostics, viral load quantification, pre‐natal testing, and GMO detection. Overall, the naica™ system’s superior performances make it a preferred technology for precision medicine research and therapeutic monitoring.
Stilla advises and supports its customers worldwide with a proactive and multidisciplinary R&D team, whose expertise spans from microfluidics and chemistry, to molecular biology and computer science. 

![](https://www.stillatechnologies.com/wp-content/uploads/2016/07/naica-system.jpg)

After completing a 20 M€ Series B funding round in January 2020, Stilla intends to accelerate the adoption & development of its next-generation solution to clinical diagnostics market worldwide. The company is looking to :

  1. expand the sales of its naica™ system worldwide
  2. scale production facilities
  3. maintain a strong R&D pipeline of innovative products for precision genetic analysis (instrumentation, consumables and assays).

Stilla is actively hiring talented and motivated individuals in Production, Sales & Marketing, Customer Support, Software & hardware Engineering, Molecular Biology etc...

If you are excited about the field of genomics and looking to building successful Life Science products based on deep technological innovation, join us !

Our Job Openings